The FDA on Monday approved the first new drug for Alzheimer’s patients in 18 years despite an advisory panel voting against it.
CBS2's Dr. Max Gomez reports.
The Market Is Rigged To Give All The Money To The Rich: The Case Of Covid Boosters – Analysis
It is much more acceptable in policy circles to talk about ways to make tax and transfer policy more progressive than ways to..
Eurasia Review